Immunotherapy of cancer.
D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002415:Cats; D006649:Histocompatibility Antigens; D006801:Humans; D007110:Immunity, Active; D007114:Immunization; D007116:Immunization, Passive; D007167:Immunotherapy; D008545:Melanoma / Q000276:immunology; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology; D009858:Oncogenic Viruses / Q000276:immunology; D011425:Propionibacterium acnes / Q000276:immunology; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology; D014611:Vaccination; D014765:Viral Vaccines
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D006649:Histocompatibility Antigens; D014765:Viral Vaccines